Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionRockefeller Capital Management L.P.
Latest Disclosed Ownership34,163 shares
Latest Disclosed Value $ 2,735,900
Rockefeller Capital Management L.P. reports 6.93% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 14, 2026 - Rockefeller Capital Management L.P. filed a 13F-HR form disclosing ownership of 34,163 shares of Edwards Lifesciences Corporation (MX:EW) valued at $2,735,900 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 16, 2026 disclosing 36,707 shares of Edwards Lifesciences Corporation. This represents a change in shares of -6.93% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 34,163 -2,544 -6.93 2,736 -12.59 0.0025
2026-03-16 2025-12-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 36,707 922 2.58 3,129 12.43 0.0056
2026-02-14 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 36,707 922 3,129 0.0029
2025-11-14 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 35,785 -6,828 -16.02 2,783 -16.48 0.0054
2025-08-14 2025-06-30 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 42,613 3,550 9.09 3,333 17.70 0.0073
2025-08-08 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 42,589 3,526 3,331 0.0042
2025-05-14 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 39,063 -1,402 -3.46 2,831 -5.79 0.0070
2025-02-13 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 40,465 -174,262 -81.16 3,005 -78.81 0.0078
2024-11-14 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 214,727 -9,925 -4.42 14,183 -31.66 0.0382
2024-08-12 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 224,652 13,027 6.16 20,753 2.62 0.0590
2024-05-14 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 211,625 14,434 7.32 20,223 34.50 0.0590
2024-02-14 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 197,191 -19,350 -8.94 15,036 0.23 0.0502
2023-11-14 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 216,541 -9,415 -4.17 15,002 -29.62 0.0579
2023-08-14 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 225,956 -41,642 -15.56 21,314 96,781.82 0.0826
2023-05-16 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 267,598 203,787 319.36 22 -99.54 0.0952
2023-03-06 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 63,811 -262,234 -80.43 4,760 -82.33 0.0239
2022-11-02 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 326,045 -4,317 -1.31 26,940 -14.24 0.1392
2022-08-12 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 330,362 2,601 0.79 31,412 -18.59 0.1669
2022-05-13 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 327,761 765 0.23 38,583 -8.92 0.1861
2022-02-14 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 326,996 6,434 2.01 42,361 16.73 0.1977
2021-11-12 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 320,562 -15,922 -4.73 36,290 4.14 0.1907
2021-08-10 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 336,484 13,673 4.24 34,848 29.07 0.1963
2021-05-11 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 322,811 12,045 3.88 26,999 -4.77 0.1827
2021-02-12 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 310,766 -24,359 -7.27 28,350 5.99 0.2147
2020-11-13 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 335,125 -3,401 -1.00 26,749 14.33 0.2506
2020-08-12 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 338,526 228,877 208.74 23,396 13.12 0.2448
2020-05-12 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 109,649 -3,961 -3.49 20,682 -21.97 0.2713
2020-02-07 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 113,610 413 0.36 26,504 6.47 0.3304
2019-11-12 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 113,197 1,722 1.54 24,894 20.88 0.3377
2019-08-09 2019-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 111,475 -3,215 -2.80 20,594 -6.15 0.2871
2019-05-10 2019-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 114,690 6,561 6.07 21,944 32.50 0.3128
2019-02-12 2018-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 108,129 -2,140 -1.94 16,562 -13.73 0.2902
2018-11-02 2018-09-30 13F Edwards Lifesciences Common 28176E108 110,269 48 0.04 19,198 19.65 0.2914
2018-07-31 2018-06-30 13F Edwards Lifesciences Common 28176E108 110,221 -23,554 -17.61 16,045 -14.03 0.2613
2018-05-09 2018-03-31 13F Edwards Lifesciences Common 28176E108 133,775 133,775 18,664 0.3084
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.